A 15-year Single Center Experience of Endovascular Treatment of Transplant Renal Artery Stenosis

NCT03477071 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1323

Last updated 2018-03-26

No results posted yet for this study

Summary

Stenosis of the renal graft arteries occurs in 1 to 26% of cases and can damage the graft. Endovascular treatment is first-line treatment. The main objective of this study is to identify the predictive factors of failure of peri-anastomotic.

Conditions

  • Unrecognized Condition

Interventions

PROCEDURE

Angioplasty for Transplant Renal Artery Stenosis (TRAS)

The angioplasty is an endovascular treatment for artery stenosis, which could be associated with stenting or not.

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV
  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2017-01-01
Completion
2017-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03477071 on ClinicalTrials.gov